In a report sent to investors and clients on Tuesday, the rating was upgraded from a "buy" to a "strong-buy".
MOH was also the subject of recent commentary from other brokerages. Cantor Fitzgerald began covering shares of Molina Health in a research report on Thursday, 20th April. They gave the company an 'overweight rating' and set a target price of $354.00. Wells Fargo & Company lowered their price target on shares of Molina Healthcare to $282.00 from $307.00 in a research report on Tuesday, March 21, and assigned an 'underweight rating'. JPMorgan Chase & Co. lowered their price target on shares of Molina Healthcare to $348.00 in a Thursday, February 23, research note. They also set an overweight' rating for the stock. Credit Suisse Group reduced its price target on shares of Molina Healthcare to $347.00 from $395.00 in a research report on Friday, 10th February. They also set an "outperform" rating for the stock. Truist Financial, in a research report published on Friday, 10th February, reduced its price target on shares of Molina Healthcare, from $400.00 down to $380.00, and gave the stock a "buy" rating. Five analysts have given the stock a buy recommendation, one has given it a sell recommendation, and another has given it a strong purchase recommendation. On Tuesday, the stock fell $4.38 to $279.28. The average trading volume for the stock is 534,007. The company has a $16.27 billion market capitalization, a 20.61 price-to earnings ratio, a P/E/G of 0.71, and a beta value of 0.67. The stock's 200-day average is $309.22 and its 50-day average is $278.44. The company's debt-to equity ratio is 0.81. Its quick ratio is 1.47, and its current ratio is 1.47. Molina Healthcare's 52-week low is $249.78, and its 52-week highest is $374.00.
The company last released its results on February 8th. The company's earnings per share were $4.10, exceeding the consensus estimate by $0.04 Revenue for the quarter was $8.22 billion, which is higher than the $7.87 billion consensus estimate. Molina Healthcare's net margin was 2.48%, and its return on equity was 36.05%. Revenue for the quarter was up by 11.0% from last year's same-quarter. In the same time period last year, the company earned $2.88 per share. Research analysts predict that Molina Healthcare's earnings per share will be 19.76 for the current fiscal year.
Insider Buying & Selling
In a transaction that took place on Friday, 3rd March, 5,000 shares were sold. The shares were sold for $276.77 on average, resulting in a value of $1383,850.00. The director now holds 4,944 shares worth approximately $1,368,350.88. Insiders control 1.10% the stock of the company.
Molina Healthcare Institutional Trading
A number of major investors have recently changed their holdings in the company. Sequoia Financial Advisors LLC has increased its shares of Molina Healthcare in the first quarter by 18.2%. Sequoia Financial Advisors LLC owns 994 of the company stock, worth $266,000, after purchasing an additional 153 during the period. Asset Management One Co. Ltd. increased their stake in Molina Healthcare during the first quarter by 2.5%. Asset Management One Co. Ltd. owns 23,437 of the company stock, valued at $6.269,000. This is after purchasing an additional 576 share during the period. Berger Financial Group Inc purchased a position in Molina Healthcare valued at approximately $4,165,000 during the first quarter. Inspire Investing LLC grew its stake in Molina Healthcare during the first quarter by 16.0%. Inspire Investing LLC owns 8,567 of the company stock, valued at $2.292,000. This is after purchasing an additional 1,182 stocks during the period. DekaBank Deutsche Girozentrale also increased its stake in Molina Healthcare during the first quarter by 7.3%. DekaBank Deutsche Girozentrale owns 94 880 shares worth $24,743,000, after purchasing 6,474 additional shares. Institutional investors and hedge fund own 94.25 percent of the company’s stock.
Molina Healthcare, Inc. provides health care services. It is divided into four segments: Medicaid Medicare Marketplace and Other. C. David Molina founded the company in 1980. It is based in Long Beach, CA.
MarketBeat.com offers a FREE daily email newsletter